Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025.
2025 · 3rd Quarter (July 1 - Sep 30)
FULCRUM THERAPEUTICS
Filed by THE MCMANUS GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- THE MCMANUS GROUP
- Client
- FULCRUM THERAPEUTICS
- Filing UUID
- 2d119c2f-8482-444b-abd6-b6e7ea6f1f39
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.